| taxon | Q16521 |
| P1542 | has effect | Rift Valley fever | Q326638 |
| P6104 | maintained by WikiProject | WikiProject Invasion Biology | Q56241615 |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P171 | parent taxon | Phlebovirus | Q3381330 |
| P225 | taxon name | Rift Valley fever virus | |
| P105 | taxon rank | species | Q7432 |
| Q33769267 | "We do not bury dead livestock like human beings": Community behaviors and risk of Rift Valley Fever virus infection in Baringo County, Kenya |
| Q46309054 | 143 Rift Valley fever virus: A virus with potential for global emergence. |
| Q37572918 | A 3-year serological and virological cattle follow-up in Madagascar highlands suggests a non-classical transmission route of Rift Valley fever virus |
| Q90791713 | A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus |
| Q64088380 | A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting |
| Q40325815 | A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge. |
| Q27468917 | A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection |
| Q36481559 | A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection |
| Q60933007 | A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus |
| Q26315336 | A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep |
| Q54942043 | A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting. |
| Q33316823 | A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. |
| Q27483604 | A SLOWLY SEDIMENTING INFECTIOUS COMPONENT OF RIFT VALLEY FEVER VIRUS |
| Q28647232 | A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania |
| Q40762623 | A comparative evaluation of methods for detecting the Rift Valley fever virus |
| Q59013070 | A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008-2010 |
| Q62486031 | A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008-2010 |
| Q40379142 | A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity |
| Q34999859 | A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses |
| Q40186455 | A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. |
| Q40197590 | A modeling approach to investigate epizootic outbreaks and enzootic maintenance of Rift Valley fever virus |
| Q40053961 | A novel highly sensitive, rapid and safe Rift Valley fever virus neutralization test |
| Q38865387 | A novel indirect ELISA based on glycoprotein Gn for the detection of IgG antibodies against Rift Valley fever virus in small ruminants |
| Q38614847 | A novel system for identification of inhibitors of rift valley Fever virus replication. |
| Q39015060 | A possible route for the introduction of Rift Valley fever virus into Egypt during 1977. |
| Q28082904 | A review of mosquitoes associated with Rift Valley fever virus in Madagascar |
| Q38962199 | A seroepidemiological study for Rift Valley fever virus in humans and domestic animals in Egypt |
| Q35027744 | A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. |
| Q34633954 | A spatially explicit metapopulation model and cattle trade analysis suggests key determinants for the recurrent circulation of rift valley Fever virus in a pilot area of madagascar highlands |
| Q28607192 | A study of Rift Valley fever virus in Morogoro and Arusha regions of Tanzania - serology and farmers' perceptions |
| Q40746393 | A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies |
| Q41012883 | A variant of Rift Valley fever virus |
| Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
| Q60032364 | ALTERATION IN VIRULENCE OF RIFT VALLEY FEVER VIRUS DURING SERIAL PASSAGE IN LAMB TESTIS CELLS |
| Q34244912 | AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis |
| Q40850399 | Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus |
| Q40106750 | Absence of Rift Valley fever virus in domestic and wild ruminants from Spain. |
| Q43088458 | Absence of Rift Valley fever virus in wild small mammals, Madagascar |
| Q36414218 | Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein |
| Q40825493 | Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters |
| Q40606098 | Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates. |
| Q27305179 | Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity |
| Q28486013 | Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development |
| Q37547173 | Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets |
| Q42778332 | Alterations in the host transcriptome in vitro following Rift Valley fever virus infection |
| Q40398800 | An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus |
| Q30419750 | An assembly model of rift valley Fever virus |
| Q40043424 | An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep |
| Q40735286 | An immunocytochemical study of the distribution of Rift Valley fever virus in the mosquito Culex pipiens |
| Q40508544 | An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in humans, domestic and wild ruminants |
| Q34113798 | An unexpected recurrent transmission of Rift Valley fever virus in cattle in a temperate and mountainous area of Madagascar |
| Q40656673 | Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment |
| Q37956499 | Animal models of Rift Valley fever virus infection |
| Q47547438 | Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound. |
| Q34031858 | Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice |
| Q43088207 | Antibodies against Rift Valley fever virus in cattle, Mozambique |
| Q39304861 | Antibodies to Rift Valley Fever Virus in Swedish U.N. Soldiers in Egypt and the Sinai |
| Q45792281 | Antibodies to Rift Valley fever virus in the human population of Sudan |
| Q40299380 | Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies |
| Q40743074 | Antigenic analysis of Rift valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains |
| Q40777781 | Antigenic and biological properties of Rift Valley fever virus isolated during the 1987 Mauritanian epidemic |
| Q40447812 | Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). |
| Q33510919 | Application of polar-orbiting, meteorological satellite data to detect flooding of Rift Valley Fever virus vector mosquito habitats in Kenya |
| Q40097349 | Arabidopsis thaliana plants expressing Rift Valley fever virus antigens: Mice exhibit systemic immune responses as the result of oral administration of the transgenic plants |
| Q40598958 | Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley fever virus |
| Q40382951 | Arbovirus surveillance of mosquitoes collected at sites of active Rift Valley fever virus transmission: Kenya, 2006-2007. |
| Q109049537 | Archaeology and contemporary emerging zoonosis: A framework for predicting future Rift Valley fever virus outbreaks |
| Q114369237 | Aspects of Bioecology of Two Rift Valley Fever Virus Vectors in Senegal (West Africa):Aedes vexansandCulex poicilipes(Diptera: Culicidae) |
| Q39611468 | Aspects of bioecology of two Rift Valley Fever Virus vectors in Senegal (West Africa): Aedes vexans and Culex poicilipes (Diptera: Culicidae). |
| Q40779650 | Assessment of an rDNA probe filter hybridization assay for the detection of Rift Valley fever virus RNA in human serum samples from the Mauritanian epidemic |
| Q40339826 | Assessment of the risk of introduction to Tunisia of the Rift Valley fever virus by the mosquito Culex pipiens |
| Q90268459 | Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya |
| Q38808444 | Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study |
| Q54217244 | Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. |
| Q37509225 | Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. |
| Q56534881 | Automated nucleic acid extraction from whole blood, B. subtilis, E. coli, and Rift Valley fever virus on a centrifugal microfluidic LabDisk |
| Q40775631 | Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins |
| Q40292297 | Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein |
| Q40573616 | Bidirectional infection and release of Rift Valley fever virus in polarized epithelial cells |
| Q30152032 | Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals |
| Q40859660 | Biochemical characterization of Rift Valley fever virus |
| Q39426015 | Biological and antigenic relationship between Rift Valley fever virus strains isolated in Egypt and Madagascar |
| Q40953172 | Biological characteristics of plaque variants of Rift Valley fever virus |
| Q46207678 | Biological parameters of patients infected by the Rift Valley fever virus in Rosso (Mauritania) |
| Q34784520 | Biology of mosquitoes that are potential vectors of Rift Valley Fever virus in different biotopes of the central highlands of Madagascar |
| Q37998608 | Breaking the chain: Rift Valley fever virus control via livestock vaccination |
| Q59351865 | CD4 T cells, CD8 T cells, and monocytes coordinate to prevent Rift Valley fever virus encephalitis |
| Q37087027 | Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs |
| Q40787176 | Characterization of Attenuated Strains of Rift Valley Fever Virus |
| Q126346533 | Characterization of Different Monoclonal and Polyclonal Antibodies for Immunohistological Detection of Rift Valley Fever Virus Antigens |
| Q38328619 | Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. |
| Q28486276 | Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus |
| Q40448667 | Characterization of Rift Valley fever virus transcriptional terminations. |
| Q89975622 | Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein |
| Q40757347 | Characterization of baculovirus-expressed Rift Valley fever virus glycoproteins synthesized in insect cells |
| Q40679919 | Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. |
| Q39686341 | Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein |
| Q38960700 | Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome |
| Q40154881 | Characterizing the effect of Bortezomib on Rift Valley Fever Virus multiplication |
| Q27305612 | Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse |
| Q59349626 | Chimaeric Rift Valley fever virus-like particle vaccine candidate production in Nicotiana benthamiana |
| Q36159670 | Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus. |
| Q92894703 | Circulation of Rift Valley Fever Virus Antibody in Cattle during Inter-Epizootic/Epidemic Periods in Selected Regions of Tanzania |
| Q40463319 | Clinical, virological and serological response of the West African dwarf sheep to experimental infection with different strains of Rift Valley fever virus |
| Q40217783 | Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity |
| Q40461500 | Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. |
| Q109049378 | Co-circulation of Rift Valley fever virus and other zoonotic arboviruses at the human-livestock-wildlife interface in KwaZulu-Natal, South Africa |
| Q38802340 | Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission |
| Q41929965 | Colorimetric Detection of Unamplified Rift Valley Fever Virus Genetic Material Using Unmodified Gold Nanoparticles. |
| Q54116240 | Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication. |
| Q28484936 | Common host-derived chemicals increase catches of disease-transmitting mosquitoes and can improve early warning systems for Rift Valley fever virus |
| Q95300602 | Comparative analysis of codon usage patterns in Rift Valley fever virus |
| Q39779815 | Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins |
| Q127732975 | Comparative evaluation of different inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 61 VG, montanide oil ISA 201 VG, and aluminum hydroxide gel |
| Q100386143 | Comparative thermo-stability of two Rift Valley fever virus vaccine candidate CL13T with a recombinant arMP-12ΔNSm21/384 |
| Q40348202 | Comparison of Enzyme-Linked Immunosorbent Assay–Based Techniques for the Detection of Antibody to Rift Valley Fever Virus in Thermochemically Inactivated Sheep Sera |
| Q35797105 | Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines |
| Q40267008 | Comparison of a recombinant nucleocapsid IgG indirect ELISA with an IgG sandwich ELISA for the detection of antibodies to Rift Valley fever virus in small ruminants |
| Q59336169 | Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens |
| Q40777161 | Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens |
| Q40242939 | Comparison of sampling techniques for Rift Valley Fever virus potential vectors, Aedes aegypti and Culex pipiens complex, in Ngorongoro District in northern Tanzania |
| Q27481664 | Comparison of techniques for demonstrating antibodies to Rift Valley fever virus |
| Q39538225 | Comparison of the Potential for Different Genetic Forms in the Culex pipiens Complex in North America to Transmit Rift Valley Fever Virus |
| Q40734116 | Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine |
| Q55262858 | Competence of mosquitoes native to the United Kingdom to support replication and transmission of Rift Valley fever virus. |
| Q101047757 | Competency of Amphibians and Reptiles and Their Potential Role as Reservoir Hosts for Rift Valley Fever Virus |
| Q38469369 | Competitive ELISA for the detection of antibodies to Rift Valley fever virus in goats and cattle |
| Q27478367 | Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry |
| Q38854980 | Complete Genome Sequence of Rift Valley Fever Virus Strain Lunyo |
| Q37244410 | Complete Genome Sequence of Two Rift Valley Fever Virus Strains Isolated from Outbreaks in Saudi Arabia (2000) and Kenya (2006 to 2007). |
| Q40816483 | Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus |
| Q40816475 | Complete sequences of the glycoproteins and M RNA of Punta Toro phlebovirus compared to those of Rift Valley fever virus |
| Q34729687 | Comprehensive phylogenetic reconstructions of Rift Valley fever virus: the 2010 northern Mauritania outbreak in the Camelus dromedarius species |
| Q38297831 | Computational prediction and biochemical characterization of novel RNA aptamers to Rift Valley fever virus nucleocapsid protein |
| Q38157556 | Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans. |
| Q54967688 | Correction: Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection. |
| Q49164360 | Correction: Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA. |
| Q40630335 | Could bats act as reservoir hosts for Rift Valley fever virus? |
| Q35531617 | Creation of a nonspreading Rift Valley fever virus |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q35140474 | Cross-sectional survey of Rift Valley fever virus exposure in Bodhei village located in a transitional coastal forest habitat in Lamu county, Kenya |
| Q24628170 | Crystal structure of glycoprotein C from Rift Valley fever virus |
| Q40817975 | Culex pipiens (Diptera: Culicidae) morbidity and mortality associated with Rift Valley fever virus infection |
| Q57261369 | Curcumin inhibits Rift Valley fever virus replication in human cells |
| Q36286082 | Curcumin inhibits Rift Valley fever virus replication in human cells. |
| Q36254960 | Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus |
| Q30000773 | Data-driven modeling to assess receptivity for Rift Valley Fever virus |
| Q35097798 | Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes |
| Q40261786 | Description and analysis of the cattle trade network in the Madagascar highlands: potential role in the diffusion of Rift Valley fever virus |
| Q41032454 | Destruction of tumour cells by Rift Valley fever virus |
| Q40279271 | Detection and identification of Rift Valley fever virus in mosquito vectors by quantitative real-time PCR. |
| Q40311093 | Detection of Puumala and Rift Valley Fever virus by quantitative RT-PCR and virus viability tests in samples of blood dried and stored on filter paper |
| Q40936109 | Detection of Rift Valley Fever Virus by the Fluorescent Antibody Technique in Organs of Experimentally Infected Animals |
| Q114348842 | Detection of Rift Valley Fever Virus in Aedes (Aedimorphus) durbanensis, South Africa |
| Q27489372 | Detection of Rift Valley fever virus antigen by enzyme-linked immunosorbent assay |
| Q40655928 | Detection of Rift Valley fever virus in mosquitoes by RT-PCR. |
| Q27488895 | Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay |
| Q34101068 | Detection of rift valley Fever virus interepidemic activity in some hotspot areas of kenya by sentinel animal surveillance, 2009-2012. |
| Q33806633 | Detection of the Northeastern African Rift Valley Fever Virus Lineage During the 2015 Outbreak in Mauritania |
| Q39823269 | Detection, isolation, and genetic characterization of Rift Valley fever virus from Anopheles (Anopheles) coustani, Anopheles (Anopheles) squamosus, and Culex (Culex) antennatus of the Haute Matsiatra region, Madagascar |
| Q27487979 | Development and Evaluation of a Real-Time Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Rift Valley Fever Virus in Clinical Specimens |
| Q38884966 | Development and characterization of Rift Valley fever virus-like particles |
| Q40237419 | Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors |
| Q40361059 | Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization |
| Q40302542 | Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories |
| Q57297218 | Development of a Quantitative RT-PCR Assay to Differentiate Rift Valley Fever Virus Smithburn Vaccine Strain from Clone 13 Vaccine Strain |
| Q40214312 | Development of a Rift Valley fever virus viremia challenge model in sheep and goats |
| Q104102277 | Development of a Visible Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for the Detection of Rift Valley Fever Virus |
| Q40573754 | Development of a diagnostic one-tube RT-PCR for the detection of Rift Valley fever virus. |
| Q59359062 | Development of monoclonal antibodies to Rift Valley Fever Virus and their application in antigen detection and indirect immunofluorescence |
| Q40231731 | Development of real-time RT-PCR for the detection of low concentrations of Rift Valley fever virus |
| Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
| Q39249793 | Differences in aerosolization of Rift Valley fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies |
| Q41034446 | Different-sized infective particles of Rift Valley fever virus |
| Q40792679 | Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells |
| Q112559422 | Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches |
| Q40660109 | Distribution of viral antigen in tissues of new-born lambs infected with Rift Valley fever virus. |
| Q102332365 | Diversity and Abundance of Potential Vectors of Rift Valley Fever Virus in the North Region of Cameroon |
| Q40481588 | Domestic transmission of Rift Valley Fever virus in Diawara (Senegal) in 1998. |
| Q35107614 | Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. |
| Q40727773 | Duration of immunoglobulin M antibodies against Rift Valley fever virus in cattle after natural infection |
| Q35606934 | Dust devil: the life and times of the fungus that causes valley Fever |
| Q26700137 | Ecological differentiation of members of the Culex pipiens complex, potential vectors of West Nile virus and Rift Valley fever virus in Algeria |
| Q47556353 | Ecological distribution and population dynamics of Rift Valley fever virus mosquito vectors (Diptera, Culicidae) in Senegal |
| Q31143311 | Ecological niche modelling of Rift Valley fever virus vectors in Baringo, Kenya |
| Q89527413 | Effect of Environmental Temperature on the Ability of Culex tarsalis and Aedes taeniorhynchus (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
| Q40954155 | Effect of Imput Multiplicity and Tissue Cell Concentration on Growth of Rift Valley Fever Virus |
| Q40767968 | Effect of Rift Valley fever virus on pregnant and non-pregnant local Barki ewes after artificial infection. |
| Q44140108 | Effect of environmental temperature on the susceptibility of Culex pipiens (Diptera: Culicidae) to Rift Valley fever virus |
| Q40777151 | Effect of environmental temperature on the vector competence of Aedes fowleri for Rift Valley fever virus |
| Q40814412 | Effect of extrinsic incubation temperature on the ability of Aedes taeniorhynchus and Culex pipiens to transmit Rift Valley fever virus |
| Q40702197 | Effect of the developmental stage at infection on the ability of adult Anopheles stephensi to transmit Rift Valley fever virus. |
| Q40686078 | Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in mice |
| Q40743768 | Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats |
| Q39198268 | Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep |
| Q40768918 | Efficacy of a sustained-release methoprene formulation on potential vectors of Rift Valley fever virus in field studies in Kenya. |
| Q50329180 | Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination |
| Q34704620 | Efficient cellular release of Rift Valley fever virus requires genomic RNA. |
| Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
| Q40397884 | Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers |
| Q40734422 | Electron microscopic identification of Zinga virus as a strain of Rift Valley fever virus |
| Q40949456 | Electron microscopic studies on BHK 21 cells infected with rift valley fever virus |
| Q35272576 | Elevated antibodies against Rift Valley fever virus among humans with exposure to ruminants in Saudi Arabia |
| Q28085230 | Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus |
| Q51043228 | Enemies and turncoats: bovine tuberculosis exposes pathogenic potential of Rift Valley fever virus in a common host, African buffalo (Syncerus caffer). |
| Q36098640 | Enhanced detection of Rift Valley fever virus using molecular assays on whole blood samples |
| Q27478096 | Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice |
| Q28361917 | Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice |
| Q90012800 | Entomological risk factors for potential transmission of Rift Valley fever virus around concentrations of livestock in Colorado |
| Q114234340 | Entomological survey of the potential vectors of Rift Valley fever virus and absence of detection of the virus genome from the vectors in various niches in the southern half of the Great Rift Valley of Ethiopia |
| Q40654394 | Enzootic activity of Rift Valley fever virus in Senegal |
| Q40819529 | Enzyme-linked immunosorbent assay for detection of Rift Valley fever virus antigen in mosquitoes |
| Q40795428 | Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. |
| Q22330892 | Epidemiological notes on some viruses isolated in Uganda; Yellow fever, Rift Valley fever, Bwamba fever, West Nile, Mengo, Semliki forest, Bunyamwera, Ntaya, Uganda S and Zika viruses |
| Q40200902 | Epidemiological study of Rift Valley fever virus in Kigoma, Tanzania |
| Q59352956 | Equine immunoglobulin F(ab') fragments protect mice from Rift Valley fever virus infection |
| Q99417554 | Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic |
| Q40272959 | European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus |
| Q30501476 | Evaluation of Factors Related to Growth of Rift Valley Fever Virus in Suspended Cell Cultures |
| Q40391443 | Evaluation of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus in sera of domestic ruminants in France |
| Q92320510 | Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen |
| Q127732298 | Evaluation of inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 201 VG |
| Q40198870 | Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen. |
| Q40426903 | Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States |
| Q31156487 | Evaluation of positive Rift Valley fever virus formalin-fixed paraffin embedded samples as a source of sequence data for retrospective phylogenetic analysis. |
| Q35902010 | Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep. |
| Q33981667 | Evidence for circulation of the rift valley fever virus among livestock in the union of Comoros |
| Q38827944 | Evidence for enzootic circulation of Rift Valley fever virus among livestock in Cameroon |
| Q124852349 | Evidence of Eretmapodites subsimplicipes and Aedes albopictus as competent vectors for Rift Valley fever virus transmission in Mayotte |
| Q26315437 | Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus |
| Q40951908 | Experimental Infection of Cattle with Pantropic Rift Valley Fever Virus |
| Q40521379 | Experimental detection of Rift Valley fever virus by reverse transcription-polymerase chain reaction assay in large samples of mosquitoes |
| Q40808330 | Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus. |
| Q33497390 | Experimental infection of three Nigerian breeds of sheep with the Zinga strain of the Rift Valley Fever virus |
| Q40348206 | Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates. |
| Q39240168 | Experimental transmission and field isolation studies implicating Culex pipiens as a vector of Rift Valley fever virus in Egypt. |
| Q47555207 | Experimental transmission of West Nile Virus and Rift Valley Fever Virus by Culex pipiens from Lebanon |
| Q125276676 | Exploring potential risk pathways with high risk groups for urban Rift Valley fever virus introduction, transmission, and persistence in two urban centers of Kenya |
| Q60031485 | Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen |
| Q52719610 | Expression of a Recombinant Nucleocapsid Protein of Rift Valley Fever Virus in Vero Cells as an Immunofluorescence Antigen and Its Use for Serosurveillance in Traditional Cattle Herds in Zambia. |
| Q54267574 | Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins. |
| Q40108424 | Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment |
| Q40663046 | Facilitation of Rift Valley fever virus transmission by Plasmodium berghei sporozoites in Anopheles stephensi mosquitoes |
| Q36957867 | Fatal outcome of hepatitis A virus (HAV) infection in a traveler with incomplete HAV vaccination and evidence of Rift Valley Fever virus infection |
| Q37683496 | Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment |
| Q64131821 | First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years |
| Q40604475 | First isolation of the Rift Valley fever virus from Culex poicilipes (Diptera: Culicidae) in nature |
| Q40911441 | Fluorescent and neutralizing antibody response to infection by Rift Valley fever virus |
| Q45839983 | Focus of Rift Valley fever virus transmission in southern Mauritania |
| Q40170227 | Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination |
| Q40059072 | Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy |
| Q34429914 | Functional analysis of Rift Valley fever virus NSs encoding a partial truncation |
| Q59359898 | Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters |
| Q40232418 | Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc. |
| Q40312818 | Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase. |
| Q40216012 | Generation and characterization of monoclonal antibodies against Rift Valley fever virus nucleoprotein. |
| Q113237941 | Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model |
| Q39601913 | Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs |
| Q27469727 | Genetic reassortment of Rift Valley fever virus in nature |
| Q44170263 | Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells |
| Q36414512 | Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains |
| Q38891360 | Genetic variation among geographic isolates of Rift Valley fever virus |
| Q90614226 | Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice |
| Q35979880 | Genome analysis of Rift Valley fever virus, Mayotte |
| Q90188394 | Genomic Characterization of Rift Valley Fever Virus, South Africa, 2018 |
| Q113266667 | Genomic surveillance of Rift Valley fever virus: from sequencing to lineage assignment |
| Q40941135 | Growth of Rift Valley fever virus in human diploid (WI-38) cells |
| Q26314582 | Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa? |
| Q58490298 | Heat stability of the Rift Valley Fever Virus Clone 13 live vaccines |
| Q40923816 | Heat- and Acid-Labile Virus-Inhibiting Factor or Interferon Induced by Rift Valley Fever Virus in Mice |
| Q40775204 | Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys |
| Q40273179 | Heparan sulfate facilitates Rift Valley fever virus entry into the cell |
| Q113265276 | Heterogeneity of Rift Valley fever virus transmission potential across livestock hosts, quantified through a model-based analysis of host viral load and vector infection |
| Q21144476 | High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses |
| Q89830499 | High risk for human exposure to Rift Valley fever virus in communities living along livestock movement routes: A cross-sectional survey in Kenya |
| Q91728993 | High seroconversion rate to Rift Valley fever virus in cattle and goats in far northern KwaZulu-Natal, South Africa, in the absence of reported outbreaks |
| Q35893112 | High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection |
| Q36314304 | Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus |
| Q33918307 | Host alternation is necessary to maintain the genome stability of rift valley fever virus |
| Q57474153 | Host-based processes as therapeutic targets for Rift Valley fever virus |
| Q90483033 | Host-feeding patterns of Aedes (Aedimorphus) vexans arabiensis, a Rift Valley Fever virus vector in the Ferlo pastoral ecosystem of Senegal |
| Q57092593 | Human Biomarkers of Outcome following Rift Valley fever virus Infection |
| Q104612990 | Human DDX17 Unwinds Rift Valley Fever Virus Non-Coding RNAs |
| Q128146393 | Human and Livestock Surveillance Revealed the Circulation of Rift Valley Fever Virus in Agnam, Northern Senegal, 2021 |
| Q41084108 | Human infection with Rift Valley fever virus and immunity twelve years after single attack. |
| Q37036679 | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus |
| Q40972593 | IMMUNIZATION AGAINST RIFT VALLEY FEVER VIRUS. STUDIES ON THE IMMUNOGENICITY OF LYOPHILIZED FORMALIN-INACTIVATED VACCINE |
| Q92081517 | Identification and evaluation of antivirals for Rift Valley fever virus |
| Q36462318 | Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay |
| Q112566646 | Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation In Vivo |
| Q40844168 | Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells |
| Q40776401 | Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus |
| Q40359899 | Identification of potential vectors of and detection of antibodies against Rift Valley fever virus in livestock during interepizootic periods |
| Q28703345 | Identifying landscape features associated with Rift Valley fever virus transmission, Ferlo region, Senegal, using very high spatial resolution satellite imagery |
| Q39193651 | IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants |
| Q40939699 | Immunofluorescent cell-counting assay of Rift Valley fever virus |
| Q89967880 | Immunogenicity Assessment of Rift Valley Fever Virus Virus-Like Particles in BALB/c Mice |
| Q40498246 | Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus |
| Q40463330 | Immunological reactions of Rift Valley fever virus strains from East and West Africa |
| Q40742126 | Impact of stressful conditions on the survival of Culex pipiens exposed to Rift Valley fever virus |
| Q40425544 | In vitro activity of Russian ribavirin on the models of Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, and Tahyna and Dhori viruses |
| Q92561288 | In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus |
| Q39197938 | Inactivation of infectious virus and serological detection of virus antigen in Rift Valley fever virus-exposed mosquitoes fixed with paraformaldehyde |
| Q40847485 | Inbred rat strains mimic the disparate human response to Rift Valley fever virus infection |
| Q40823678 | Increased Mosquito Feeding on Rift Valley Fever Virus-Infected Lambs * |
| Q129449611 | Increasing evolution, prevalence, and outbreaks for rift valley fever virus in the process of breaking geographical barriers |
| Q40556173 | Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q40545597 | Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus. |
| Q40919649 | Induction of virus-inhibiting factor or interferon in mice by strains with different virulence of Rift Valley fever virus |
| Q40748547 | Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance |
| Q40146936 | Infectious, immunogenic, and protective characteristics of the Rift Valley fever virus depending on the passage level and storage conditions |
| Q40775294 | Ingestion of immune bloodmeals and infection of Aedes fowleri, Aedes mcintoshi, and Culex pipiens with Rift Valley fever virus. |
| Q34597759 | Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin |
| Q41025328 | Inhibition of multiplication of Rift Valley fever virus by homologous virus irradiated by ultraviolet rays |
| Q34251382 | Innate immune response to Rift Valley fever virus in goats |
| Q38677880 | Inter-epidemic Rift Valley fever virus seroconversions in an irrigation scheme in Bura, south-east Kenya |
| Q35002597 | Inter-epidemic abundance and distribution of potential mosquito vectors for Rift Valley fever virus in Ngorongoro district, Tanzania |
| Q35130104 | Inter-epidemic acquisition of Rift Valley fever virus in humans in Tanzania. |
| Q40717906 | Interacting factors that influence long-term storage of live Pasteurella tularensis vaccine and Rift Valley fever virus |
| Q37009607 | Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya |
| Q41015617 | Interference between active and ultraviolet-irradiated Rift Valley fever virus |
| Q40595885 | Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. |
| Q21562243 | International external quality assessment of molecular detection of Rift Valley fever virus |
| Q53682526 | Interspecific network centrality, host range and early-life development are associated with wildlife hosts of Rift Valley fever virus. |
| Q45372924 | Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? |
| Q40368584 | Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus |
| Q40257752 | Is the United States really at risk for introduction of Rift Valley fever virus? |
| Q27489553 | Isolation and Genetic Characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia |
| Q45329064 | Isolation and phylogenetic study of Rift Valley fever virus from the first imported case to China |
| Q40751582 | Isolation of Rift Valley Fever Virus from Mosquitoes (Diptera: Culicidae) Collected During an Outbreak in Domestic Animals in Kenya |
| Q40816030 | Isolation of Rift Valley fever virus from cattle abortions in Tanzania |
| Q40775515 | Isolation of Rift Valley fever virus from human peripheral blood mononuclear cells: Mauritanian epidemic |
| Q40779658 | Isolation of the Rift Valley fever virus by inoculation into Aedes pseudoscutellaris cells: comparison with other diagnostic methods |
| Q40417897 | Kinetics of Rift Valley Fever Virus in experimentally infected mice using quantitative real-time RT-PCR. |
| Q112761053 | Laboratory demonstration of the vertical transmission of Rift Valley fever virus by Culex tarsalis mosquitoes |
| Q40400233 | Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA. |
| Q40521383 | Laboratory transmission of Rift Valley fever virus by Phlebotomus duboscqi, Phlebotomus papatasi, Phlebotomus sergenti, and Sergentomyia schwetzi (Diptera: Psychodidae). |
| Q36353686 | Landscape Genetics of Aedes mcintoshi (Diptera: Culicidae), an Important Vector of Rift Valley Fever Virus in Northeastern Kenya |
| Q40277454 | Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome |
| Q57807115 | Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Adult Sheep |
| Q92015434 | Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Young Lambs |
| Q66678817 | Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir |
| Q40908064 | Long term existence of Rift Valley Fever virus in immune mice |
| Q40324199 | Lymphoplasmacytic endotheliitis and anterior uveitis in sheep infected experimentally with rift valley fever virus |
| Q112639457 | MAVS mediates a protective immune response in the brain to Rift Valley fever virus |
| Q113258971 | MONITORING OF THE ANTIVIRAL POTENTIAL OF BEE VENOM AND WAX EXTRACTS AGAINST ADENO-7 (DNA) AND RIFT VALLEY FEVER VIRUS (RNA) VIRUSES MODELS |
| Q35792819 | MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters |
| Q89719752 | MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses |
| Q40132046 | Mapping a Major Gene for Resistance to Rift Valley Fever Virus in Laboratory Rats |
| Q40642621 | Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation |
| Q40848509 | Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates |
| Q40821129 | Mechanical transmission of Rift Valley fever virus by hematophagous Diptera |
| Q34490520 | Mechanism of tripartite RNA genome packaging in Rift Valley fever virus |
| Q28554535 | Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence |
| Q125118830 | Mechanistic models of Rift Valley fever virus transmission: A systematic review |
| Q40808123 | Messenger RNA of the M segment RNA of Rift Valley fever virus |
| Q91640363 | Methods for successful inactivation of Rift Valley fever virus in infected mosquitoes |
| Q92947590 | Microencapsulated plasmids expressing Gn and Gc glycoproteins of Rift Valley Fever virus enhance humoral immune response in mice |
| Q63707129 | Modeling the Tertiary Structure of the Rift Valley Fever Virus L Protein |
| Q125922559 | Modeling the effectiveness of targeting Rift Valley fever virus vaccination using imperfect network information |
| Q30421040 | Modelling the effects of seasonality and socioeconomic impact on the transmission of rift valley Fever virus |
| Q59467623 | Modelling the use of impulsive vaccination to control Rift Valley Fever virus transmission |
| Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
| Q59351098 | Molecular aspects of Rift Valley fever virus and the emergence of reassortants |
| Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
| Q33886954 | Molecular biology of rift valley Fever virus |
| Q40220077 | Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania |
| Q35849036 | Molecular epidemiology of Rift Valley fever virus |
| Q40154443 | Monitoring of the antiviral potential of bee venom and wax extracts against Adeno-7 (DNA) and Rift Valley fever virus (RNA) viruses models. |
| Q45806308 | Monoclonal antibodies to identify Zinga virus as Rift Valley Fever virus |
| Q38991875 | Morphology and development of Rift Valley fever virus in Vero cell cultures |
| Q24701810 | Mosquito host choices on livestock amplifiers of Rift Valley fever virus in Kenya |
| Q40083734 | Mouse model for the Rift Valley fever virus MP12 strain infection. |
| Q33583806 | Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors |
| Q38845048 | Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine. |
| Q41003192 | Multiplication of Rift Valley fever virus in human liver cell culture with special reference to production complement fixing antigen. |
| Q41024803 | Multiplication of neurotropic Rift Valley fever virus in Ehrlich ascites tumor cells. |
| Q41010911 | Multiplication of the neurotropic strain of Rift Valley fever virus in the spleen and liver of mice |
| Q40814834 | Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development |
| Q54257544 | Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice. |
| Q37049951 | Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. |
| Q36947068 | N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN. |
| Q35024013 | NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. |
| Q36315241 | NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis |
| Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
| Q96952294 | NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice |
| Q39960501 | NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q39547955 | NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. |
| Q38601911 | NSs protein of severe fever with thrombocytopenia syndrome virus suppresses interferon production through different mechanism than Rift Valley fever virus |
| Q101146923 | Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein |
| Q64126219 | Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus |
| Q92680166 | Neutralizing antibodies against Rift Valley fever virus in wild antelope in far northern KwaZulu-Natal, South Africa, indicate recent virus circulation |
| Q51336493 | Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats. |
| Q40988106 | Neutralizing antibody response of sheep to pantropic and neutrotropic rift valley fever virus |
| Q40130716 | Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells. |
| Q39778891 | Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. |
| Q40730767 | Nonvascular delivery of Rift Valley fever virus by infected mosquitoes |
| Q27027003 | Novel approaches to develop Rift Valley fever vaccines |
| Q39676525 | Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles |
| Q91034554 | Nuclear pore protein Nup98 is involved in replication of Rift Valley fever virus and nuclear import of virulence factor NSs |
| Q37252699 | Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene |
| Q35690127 | Observations on rift valley fever virus and vaccines in Egypt |
| Q40864346 | Ocular disease resulting from infection with Rift Valley fever virus |
| Q40439262 | Optical fiber immunosensor for the detection of IgG antibody to Rift Valley fever virus in humans |
| Q43167772 | Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. |
| Q98948564 | Ovine Fetal and Placental Lesions and Cellular Tropism in Natural Rift Valley Fever Virus Infections |
| Q40968999 | PROTECTION OF MICE AND LAMBS AGAINST PANTROPIC RIFT VALLEY FEVER VIRUS, USING IMMUNE SERUM |
| Q40982522 | PURIFICATION AND ELECTRON MICROSCOPY OF PANTROPIC RIFT VALLEY FEVER VIRUS. |
| Q40049043 | Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method |
| Q40744759 | Palmitoylation of cysteine 69 from the COOH-terminal of band 3 protein in the human erythrocyte membrane. Acylation occurs in the middle of the consensus sequence of F--I-IICLAVL found in band 3 protein and G2 protein of Rift Valley fever virus |
| Q41065298 | Pantotropic virus. IV. Rift Valley fever virus |
| Q40785341 | Panveld oviposition sites of floodwater Aedes mosquitoes and attempts to detect transovarial transmission of Rift Valley fever virus in South Africa |
| Q38957617 | Paramyxovirus-based production of Rift Valley fever virus replicon particles |
| Q40616443 | Pathogen-specific resistance to Rift Valley fever virus infection is induced in mosquito cells by expression of the recombinant nucleoprotein but not NSs non-structural protein sequences |
| Q59350395 | Pathogenesis of Rift Valley Fever Virus Aerosol Infection in Knockout Hamsters |
| Q40798305 | Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats |
| Q39407293 | Pathogenesis of Rift Valley fever virus in mosquitoes--tracheal conduits & the basal lamina as an extra-cellular barrier. |
| Q39442255 | Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs. |
| Q40795447 | Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes |
| Q27481366 | Pathogenicity of different strains of Rift Valley fever virus in Swiss albino mice |
| Q90695793 | Patterns of Rift Valley fever virus seropositivity in domestic ruminants in central South Africa four years after a large outbreak |
| Q40660523 | Persistent infection of mammalian cells by Rift Valley fever virus |
| Q128975714 | Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus |
| Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
| Q40191372 | Phylogeographic Reconstructions of a Rift Valley Fever Virus Strain Reveals Transboundary Animal Movements from Eastern Continental Africa to the Union of the Comoros |
| Q28469517 | Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula |
| Q34249345 | Phylogeography of Rift Valley Fever virus in Africa reveals multiple introductions in Senegal and Mauritania |
| Q28742390 | Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission |
| Q41027391 | Plaque formation with Rift Valley fever virus |
| Q113283497 | Polyamine-Linked Cholesterol Incorporation in Rift Valley Fever Virus Particles Promotes Infectivity |
| Q34633660 | Population genetics of two key mosquito vectors of Rift Valley Fever virus reveals new insights into the changing disease outbreak patterns in Kenya |
| Q36879979 | Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge |
| Q34000103 | Postepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort study |
| Q40114294 | Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo |
| Q40296536 | Potential for Canadian mosquitoes to transmit Rift Valley fever virus |
| Q40346522 | Potential for North American Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
| Q40398345 | Potential for North American mosquitoes to transmit Rift Valley fever virus |
| Q40140711 | Potential for Psorophora columbiae and Psorophora ciliata Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus |
| Q37166123 | Potential for autoimmune pathogenesis of Rift Valley Fever virus retinitis |
| Q40751106 | Potential for mosquito transmission of attenuated strains of Rift Valley fever virus |
| Q40229732 | Potential for mosquitoes (Diptera: Culicidae) from Florida to transmit Rift Valley fever virus |
| Q40238831 | Potential for populations of Aedes j. japonicus to transmit Rift Valley fever virus in the USA. |
| Q40335291 | Potential for stable flies and house flies (Diptera: Muscidae) to transmit Rift Valley fever virus |
| Q40414505 | Potential vectors of Rift Valley fever virus in the Mediterranean region |
| Q92043717 | Predicting Abundances of Aedes mcintoshi, a primary Rift Valley fever virus mosquito vector |
| Q37231456 | Predicting distribution of Aedes aegypti and Culex pipiens complex, potential vectors of Rift Valley fever virus in relation to disease epidemics in East Africa |
| Q34165833 | Predicting the mosquito species and vertebrate species involved in the theoretical transmission of Rift Valley fever virus in the United States |
| Q59352849 | Preliminary evaluation of diagnostic accuracy and precision of a competitive ELISA for detection of antibodies to Rift Valley fever virus in cattle and sheep sera |
| Q27482801 | Preliminary survey of domestic animals of the Sudan for precipitating antibodies to Rift Valley fever virus |
| Q128091477 | Preparation and Evaluation of Antigens of Rift Valley Fever Virus |
| Q40462117 | Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. |
| Q36568775 | Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection |
| Q28752180 | Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife |
| Q40782788 | Prevalence of antibodies against Rift Valley fever virus in sheep and goats in Senegal |
| Q38953827 | Prevalence of antibody to Rift Valley fever virus in the Nile river delta of Egypt, 13 years after a major outbreak |
| Q39953693 | Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. |
| Q40501140 | Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera |
| Q41028566 | Propagation of Rift Valley fever virus in ascites hepatoma cells of the rat: production of a new variant of the virus |
| Q40815181 | Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice |
| Q40202028 | Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome |
| Q40365121 | Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. |
| Q40321756 | Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus |
| Q34431934 | Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine |
| Q35912398 | Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase |
| Q36668959 | Protein Phosphatase-1 regulates Rift Valley fever virus replication |
| Q40827849 | Protein synthesis in Rift Valley fever virus-infected cells |
| Q38964465 | Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States. |
| Q39467349 | Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds |
| Q33634293 | RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems |
| Q36759999 | RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge |
| Q40504138 | Rainfall patterns and population dynamics of Aedes (Aedimorphus) vexans arabiensis, Patton 1905 (Diptera: Culicidae), a potential vector of Rift Valley Fever virus in Senegal. |
| Q35541050 | Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death |
| Q38820203 | Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis |
| Q27491320 | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA |
| Q27471311 | Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. |
| Q40241939 | Re-emergence of Rift Valley fever virus in Barkedji (Senegal, West Africa) in 2002-2003: identification of new vectors and epidemiological implications |
| Q95826961 | Reagents for detection of Rift Valley fever virus infection in sheep |
| Q27487305 | Real-Time Reverse-Transcription Loop-Mediated Isothermal Amplification for Rapid Detection of Rift Valley Fever Virus |
| Q35769810 | Reassortment and distinct evolutionary dynamics of Rift Valley Fever virus genomic segments |
| Q45324172 | Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection. |
| Q40744262 | Recombinant Human Interferon-γ Modulates Rift Valley Fever Virus Infection in the Rhesus Monkey |
| Q40438632 | Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo |
| Q34280142 | Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virus |
| Q40781570 | Reduced Rift Valley fever virus infection rates in mosquitoes associated with pledget feedings. |
| Q40848409 | Reduced pathogenicity associated with a small plaque variant of the Egyptian strain of Rift Valley fever virus (ZH501). |
| Q40806403 | Reduced recovery of Rift Valley fever virus associated with assay of mosquito (Diptera: Culicidae) larval pools |
| Q40793941 | Reduced survival of adult Culex pipiens infected with Rift Valley fever virus |
| Q40930978 | Relationship Between Plaque Assay and the Mouse Assay for Titrating Rift Valley Fever Virus |
| Q39356757 | Remote sensing and geographic information systems to predict the density of ruminants, hosts of Rift Valley fever virus in the Sahel. |
| Q40830060 | Replication and dissemination of Rift Valley fever virus in Culex pipiens. |
| Q40348212 | Replication of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, in Aedes and Culex mosquitoes |
| Q40828705 | Replication of Rift Valley fever virus in the sand fly Lutzomyia longipalpis. |
| Q35718193 | Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection |
| Q40311587 | Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene |
| Q40613342 | Resistance to Rift Valley fever virus in Rattus norvegicus: genetic variability within certain 'inbred' strains |
| Q38892505 | Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus |
| Q38614407 | Restriction of rift valley Fever virus virulence in mosquito cells |
| Q40857512 | Retinal abnormalities caused by Rift Valley fever virus |
| Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
| Q33745109 | Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells |
| Q59178622 | Rift Valley Fever Virus |
| Q27928016 | Rift Valley Fever Virus Circulating among Ruminants, Mosquitoes and Humans in the Central African Republic |
| Q34034059 | Rift Valley Fever Virus Epidemic in Kenya, 2006/2007: The Entomologic Investigations |
| Q64130624 | Rift Valley Fever Virus Exposure amongst Farmers, Farm Workers, and Veterinary Professionals in Central South Africa |
| Q40983070 | Rift Valley Fever Virus Hepatitis: Light and Electron Microscopic Studies in the Mouse |
| Q99711464 | Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex |
| Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
| Q112069828 | Rift Valley Fever Virus Seroprevalence among Humans, Northern KwaZulu-Natal Province, South Africa, 2018-2019 |
| Q36418114 | Rift Valley Fever Virus among Wild Ruminants, Etosha National Park, Namibia, 2011. |
| Q64127190 | Rift Valley Fever Virus and Yellow Fever Virus in Urine: A Potential Source of Infection |
| Q92543320 | Rift Valley Fever Virus, Japanese Encephalitis Virus, and African Swine Fever Virus: Three Transboundary, Vector-Borne, Veterinary Biothreats With Diverse Surveillance, and Response Capacity Needs |
| Q91432348 | Rift Valley Fever Virus: Propagation, Quantification, and Storage |
| Q38991879 | Rift Valley Fever Virus: Some Ultrastructural Observations on Material from the Outbreak in Egypt 1977 |
| Q108990650 | Rift Valley Fever Virus—How and Where Virus Is Maintained During Inter-epidemic Periods |
| Q40259783 | Rift Valley Fever virus in mice. I. General features of the infection |
| Q40259887 | Rift Valley Fever virus in mice. II. Adsorption and multiplication of virus |
| Q40260149 | Rift Valley Fever virus in mice. III. Further quantitative features of the infective process |
| Q40260073 | Rift Valley Fever virus in mice. IV. Incomplete virus; its production and properties |
| Q38855401 | Rift Valley Fever virus infections in Egypt: pathological and virological findings in man |
| Q40513778 | Rift Valley fever virus |
| Q34971963 | Rift Valley fever virus |
| Q56503351 | Rift Valley fever virus |
| Q27482900 | Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya |
| Q40700712 | Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases |
| Q40785843 | Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA. |
| Q40783794 | Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins |
| Q40774379 | Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation |
| Q40129877 | Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression |
| Q37006803 | Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice |
| Q40137585 | Rift Valley fever virus NSS gene expression correlates with a defect in nuclear mRNA export |
| Q36501737 | Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. |
| Q40499504 | Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment |
| Q26745530 | Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins |
| Q33406230 | Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation |
| Q40735889 | Rift Valley fever virus activity in East Africa in 1989 |
| Q40044386 | Rift Valley fever virus and European mosquitoes: vector competence of Culex pipiens and Stegomyia albopicta (= Aedes albopictus). |
| Q36827204 | Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses |
| Q40581805 | Rift Valley fever virus ecology and the epidemiology of disease emergence |
| Q39877530 | Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector |
| Q45332431 | Rift Valley fever virus imported into China from Angola |
| Q36154746 | Rift Valley fever virus in mice. V. The properties of a haemagglutinin present in infective serum |
| Q41011867 | Rift Valley fever virus in mice. VI. Histological changes in the liver in relation to virus multiplication |
| Q91241995 | Rift Valley fever virus in small ruminants in the Democratic Republic of the Congo |
| Q40679927 | Rift Valley fever virus in the cardia of Culex pipiens: an immunocytochemical and ultrastructural study. |
| Q31149260 | Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. |
| Q59792732 | Rift Valley fever virus induces fetal demise in Sprague-Dawley rats through direct placental infection |
| Q57261359 | Rift Valley fever virus induces fetal demise through direct placental infection |
| Q42537845 | Rift Valley fever virus infection among French troops in Chad |
| Q34707871 | Rift Valley fever virus infection in African buffalo (Syncerus caffer) herds in rural South Africa: evidence of interepidemic transmission |
| Q28543047 | Rift Valley fever virus infection in golden Syrian hamsters |
| Q37634027 | Rift Valley fever virus infection induces activation of the NLRP3 inflammasome |
| Q39200964 | Rift Valley fever virus infections in Egyptian cattle and their prevention |
| Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
| Q40453546 | Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. |
| Q62477483 | Rift Valley fever virus minigenome system for investigating the role of L protein residues in viral transcription and replication |
| Q92558340 | Rift Valley fever virus minigenome system for investigating the role of L protein residues in viral transcription and replication |
| Q40289172 | Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis |
| Q33644365 | Rift Valley fever virus seroprevalence in human rural populations of Gabon |
| Q36397378 | Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis |
| Q40237478 | Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. |
| Q36797004 | Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. |
| Q39754768 | Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge |
| Q92802082 | Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas |
| Q39015055 | Rift Valley fever virus transmission by different Egyptian mosquito species |
| Q90093666 | Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses |
| Q34221766 | Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep |
| Q40817416 | Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans |
| Q40847013 | Rift Valley fever virus vaccine trial: study of side-effects in humans |
| Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
| Q40727210 | Rift Valley fever virus-induced encephalomyelitis and hepatitis in calves |
| Q92428167 | Rift Valley fever virus-infected mosquito ova and associated pathology: possible implications for endemic maintenance |
| Q26795706 | Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe |
| Q30151926 | Rift Valley fever virus: Unanswered questions |
| Q39368427 | Rift Valley fever virus: a seroepidemiologic study of small terrestrial vertebrates in South Africa |
| Q59351110 | Rift Valley fever virus: a serological survey in Libyan ruminants |
| Q40360325 | Rift Valley fever virus: an unrecognized emerging threat? |
| Q38471692 | Rift Valley fever virus: evolution in progress |
| Q127149927 | Rift Valley fever virus: future emergence and the impact on One Health |
| Q38757716 | Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes |
| Q28539632 | Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model |
| Q40377637 | Rift valley fever virus L protein forms a biologically active oligomer |
| Q41005187 | Rift valley fever virus in the one-day-old chick embryo |
| Q58581107 | Rift valley fever virus infection among livestock handlers in Ibadan, Nigeria |
| Q40864281 | Rift valley fever virus infection in man in Nigeria |
| Q33760778 | Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon |
| Q36484009 | Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals |
| Q33755025 | Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system |
| Q112272007 | Risk factors for Rift Valley fever virus seropositivity in one-humped camels (Camelus dromedarius) and pastoralist knowledge and practices in Northern Nigeria |
| Q30227254 | Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007. |
| Q39046970 | Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis. |
| Q39406139 | Roles of the coding and noncoding regions of rift valley Fever virus RNA genome segments in viral RNA packaging |
| Q40645625 | Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle |
| Q98164938 | Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle |
| Q40645618 | Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids |
| Q40900988 | Selection of avirulent variants of Rift Valley fever virus. |
| Q40220083 | Sensitivity and specificity of real-time reverse transcription polymerase chain reaction, histopathology, and immunohistochemical labeling for the detection of Rift Valley fever virus in naturally infected cattle and sheep |
| Q40844069 | Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. I. Macroscopic and microscopic pathology |
| Q40844064 | Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. II. Ultrastructural findings |
| Q104796638 | Sero-prevalence of West Nile virus and Rift Valley fever virus infections among cattle under extensive production system in South Omo area, southern Ethiopia |
| Q36359356 | Seroepidemiological Study of Interepidemic Rift Valley Fever Virus Infection Among Persons with Intense Ruminant Exposure in Madagascar and Kenya |
| Q40077385 | Seroepidemiological Survey of Rift Valley Fever Virus in Ruminants in Garissa, Kenya |
| Q40243781 | Seroepidemiological study of west nile virus and rift valley Fever virus in some of Mammalian species (herbivores) in northern Turkey |
| Q36371106 | Serologic evidence of exposure to Rift Valley fever virus detected in Tunisia |
| Q40062059 | Serological Evidence for the Circulation of Rift Valley Fever Virus in Domestic Small Ruminants in Southern Gabon |
| Q28606628 | Serological Evidence of Rift Valley Fever Virus Circulation in Domestic Cattle and African Buffalo in Northern Botswana (2010-2011) |
| Q40075001 | Serological and genomic evidence of Rift Valley fever virus during inter-epidemic periods in Mauritania |
| Q103838108 | Serological evidence of Rift Valley fever virus among humans in Mersin province of Turkey |
| Q34613594 | Serological evidence of Rift Valley fever virus circulation in sheep and goats in Zambézia Province, Mozambique |
| Q108990728 | Serological evidence of Rift Valley fever virus infection among domestic ruminant herds in Uganda |
| Q91969216 | Serological evidence of Rift Valley fever virus infection in slaughtered ruminants in Nigeria |
| Q45806269 | Serological evidence of endemic Zinga virus and Rift Valley Fever virus in Central African Republic |
| Q59351265 | Serological evidence of inter-epizootic/inter-epidemic circulation of Rift Valley fever virus in domestic cattle in Kyela and Morogoro, Tanzania |
| Q27469092 | Serological evidence of rift valley fever virus among acute febrile patients in Southern Mozambique during and after the 2013 heavy rainfall and flooding: implication for the management of febrile illness |
| Q115452473 | Serological evidence of the circulation of the Rift Valley fever virus in sheep and goats slaughtered in Yaoundé, Cameroon |
| Q45806715 | Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup |
| Q40153798 | Serological surveillance studies confirm the Rift Valley fever virus free status in South Korea |
| Q97568413 | Seropositivity and associated intrinsic and extrinsic factors for Rift Valley fever virus occurrence in pastoral herds of Nigeria: a cross sectional survey |
| Q94524967 | Seroprevalence and factors associated with seropositivity to Rift Valley fever virus in livestock |
| Q47549408 | Seroprevalence of Rift Valley Fever Virus Antibodies in Cattle in Mali, 2005-2014. |
| Q57806005 | Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo |
| Q115364730 | Seroprevalence of Rift Valley fever virus in domestic ruminants of various origins in two markets of Yaoundé, Cameroon |
| Q36337127 | Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15. |
| Q37067311 | Seroprevalence of Rift Valley fever virus in sheep and goats in Zambézia, Mozambique |
| Q39501218 | Seroprevalence of Rift Valley fever virus infection in camels (dromedaries) in northern Tanzania |
| Q101238016 | Serosurvey on Sheep Unravel Circulation of Rift Valley Fever Virus in Nigeria |
| Q40666023 | Serum antibody to Rift Valley fever virus in African carnivores |
| Q33436753 | Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015 |
| Q100313676 | Shedding of Rift Valley fever virus by infected sheep and by sheep protected by BCG and RVF vaccines |
| Q37433779 | Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells |
| Q40450475 | Short report: efficient oral infection of Culex pipiens quinquefasciatus by Rift Valley fever virus using a cotton stick support. |
| Q34258654 | Simulation modelling of population dynamics of mosquito vectors for rift valley Fever virus in a disease epidemic setting |
| Q36109044 | Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments |
| Q36326847 | Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates |
| Q35868079 | Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge |
| Q37673160 | Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge |
| Q27488344 | Single-particle cryo-electron microscopy of Rift Valley fever virus |
| Q40609304 | Single-tube and nested reverse transcriptase-polymerase chain reaction for detection of Rift Valley fever virus in human and animal sera |
| Q35272564 | Sociocultural and economic dimensions of Rift Valley fever |
| Q27488299 | Solid-phase immunosorbent technique for rapid detection of Rift Valley fever virus immunoglobulin M by hemagglutination inhibition |
| Q128176619 | Some Virological Studies on Rift Valley Fever Virus in Camels |
| Q38631743 | Sorafenib impedes Rift Valley fever virus egress by inhibiting Valosin-containing protein function in the cellular secretory pathway |
| Q128022332 | Spatial Modeling of Mosquito Vectors for Rift Valley Fever Virus in Northern Senegal: Integrating Satellite-Derived Meteorological Estimates in Population Dynamics Models |
| Q36632198 | Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. |
| Q45894467 | Spread of Rift Valley fever virus from continental Africa |
| Q33792385 | Stability of Rift Valley fever virus at 4 C |
| Q92343247 | Structure of a functional cap-binding domain in Rift Valley fever virus L protein |
| Q27662293 | Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation |
| Q46875187 | Studies on Neurotropic Rift Valley Fever Virus: The Susceptibility of Rodents |
| Q93893736 | Studies on Neurotropic Rift Valley Fever Virus: The Susceptibility of Sheep and Monkeys |
| Q93893733 | Studies on Neurotropic Rift Valley Fever Virus: “Spontaneous” Encephalomyelitis in Mice |
| Q40436634 | Study on DNA immune of envelope protein gene of Rift Valley Fever Virus |
| Q31037099 | Surveillance of Rift Valley Fever Virus in Mosquito Vectors of the Republic of Korea. |
| Q112069653 | Susceptibility and barriers to infection of Colorado mosquitoes with Rift Valley fever virus |
| Q38984861 | Susceptibility of CER cell line to Rift Valley Fever virus |
| Q56555971 | Susceptibility of White-Tailed Deer to Rift Valley Fever Virus |
| Q42987348 | Susceptibility of selected strains of Australian mosquitoes (Diptera: Culicidae) to Rift Valley fever virus |
| Q40233812 | Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins |
| Q56906655 | Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016 |
| Q39946457 | T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus |
| Q40980838 | THE EFFECT OF RECENTLY ISOLATED STRAINS OF RIFT VALLEY FEVER VIRUS ON LAMB TESTIS CELL CULTURES. |
| Q40969004 | TITRATION OF RIFT VALLEY FEVER VIRUS IN HAMSTER KIDNEY CELLS IN THE ABSENCE OF SERUM |
| Q35679057 | Targeting TFIIH to inhibit host cell transcription by Rift Valley Fever Virus |
| Q40579610 | Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. |
| Q36506825 | The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function |
| Q40935546 | The Clinical Aspects of Rift Valley Fever Virus in Household Pets.: I. Susceptibility of the Dog |
| Q40935256 | The Clinical Aspects of Rift Valley Fever Virus in Household Pets.: III. Pathologic Changes in the Dog and Cat |
| Q40935264 | The Clinical Aspects of Rift Valley Fever Virus in Household Pets: II. Susceptibility of the Cat |
| Q40784119 | The Distribution of Rift Valley Fever Virus in the Mosquito Culex Pipiens as Revealed by Viral Titration of Dissected Organs and Tissues |
| Q55646154 | The Dominant-Negative Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR Increases the Efficacy of Rift Valley Fever Virus MP-12 Vaccine. |
| Q55408029 | The Filtration of Rift Valley Fever Virus through Graded Collodion Membranes. |
| Q39870549 | The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules |
| Q36694012 | The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype |
| Q40499509 | The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization |
| Q27485926 | The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection |
| Q100761202 | The NSs protein encoded by the virulent strain of Rift Valley fever virus targets the expression of Abl2 and the actin cytoskeleton of the host affecting cell mobility, cell shape and cell-cell adhesion |
| Q34354086 | The Rift Valley Fever virus protein NSm and putative cellular protein interactions |
| Q40630761 | The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus |
| Q40878566 | The Rift Valley fever virus, agent of dengue-like epidemics: its geographical distribution and public health problems |
| Q27469709 | The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. |
| Q35097103 | The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging |
| Q40987065 | The development of a formalin-killed Rift Valley fever virus vaccine for use in man. |
| Q41065007 | The development of neurotropism in Rift Valley fever virus |
| Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
| Q40144461 | The effect of Rift Valley fever virus Clone 13 vaccine on semen quality in rams. |
| Q39017952 | The effect of laboratory colonization on the vector-pathogen interactions of Egyptian Culex pipiens and Rift Valley fever virus |
| Q30416792 | The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity |
| Q27311874 | The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes |
| Q40781526 | The horizontal distribution of Aedes pupae and their subsequent adults within a flooded dambo in Kenya: implications for Rift Valley fever virus control |
| Q63246310 | The influence of raw milk exposures on Rift Valley fever virus transmission |
| Q40306367 | The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus |
| Q34634852 | The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses |
| Q34191969 | The pathogenesis of Rift Valley fever |
| Q40348320 | The pathogenesis of Rift Valley fever virus in the mouse model |
| Q40921346 | The pathogenicity of rift valley fever virus for the baboon |
| Q40621269 | The potential role of rodents in the enzootic cycle of Rift Valley fever virus in Senegal |
| Q37433782 | The risk of Rift Valley fever virus introduction and establishment in the United States and European Union |
| Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
| Q38001682 | The role of wild mammals in the maintenance of Rift Valley fever virus |
| Q40847113 | The susceptibility of Culicoides variipennis Coq. (Diptera: Ceratopogonidae) to laboratory infection with Rift Valley fever virus |
| Q40738802 | The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins |
| Q37071493 | The transmission potential of Rift Valley fever virus among livestock in the Netherlands: a modelling study |
| Q37509231 | The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis |
| Q34828833 | The use of NanoTrap particles as a sample enrichment method to enhance the detection of Rift Valley Fever Virus |
| Q35644546 | The use of Nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein |
| Q40677165 | The use of sucrose-acetone-extracted Rift Valley fever virus antigen derived from cell culture in an indirect enzyme-linked immunosorbent assay and haemagglutination-inhibition test |
| Q27487138 | Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography |
| Q128630820 | Threshold Dynamics in a Periodic Three-Patch Rift Valley Fever Virus Transmission Model |
| Q34097995 | Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. |
| Q40755091 | Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies |
| Q26865198 | Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean |
| Q34677989 | Towards a safe, effective vaccine for Rift Valley fever virus |
| Q64938159 | Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs. |
| Q36542318 | Transmission Dynamics of Rift Valley Fever Virus: Effects of Live and Killed Vaccines on Epizootic Outbreaks and Enzootic Maintenance |
| Q40755728 | Transmission of Rift Valley fever virus by adult mosquitoes after ingestion of virus as larvae |
| Q39015037 | Transmission of Rift Valley fever virus by different geographic strains of Culex pipiens in Egypt |
| Q40765222 | Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae). |
| Q47560206 | Transmission of Rift Valley fever virus from European-breed lambs to Culex pipiens mosquitoes. |
| Q37020531 | Transmission potential of Rift Valley fever virus over the course of the 2010 epidemic in South Africa. |
| Q40802503 | Transmission studies in mosquitoes (Diptera: Culicidae) with disseminated Rift Valley fever virus infections |
| Q40770401 | Transstadial and horizontal transmission of Rift Valley fever virus in Hyalomma truncatum |
| Q40715732 | Ultrafiltration as a Method for Concentrating Rift Valley Fever Virus Grown in Tissue Culture |
| Q40283964 | Ultrastructural study of Rift Valley fever virus in the mouse model |
| Q113265260 | Urban risk factors for human Rift Valley fever virus exposure in Kenya |
| Q35041237 | Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus |
| Q40759549 | Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine |
| Q40805522 | Use of the avidin-biotin-peroxidase complex immunocytochemical procedure for detection of Rift Valley fever virus in paraffin sections of mosquitoes |
| Q35841573 | Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy |
| Q39066685 | Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine. |
| Q33617793 | Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus |
| Q112416141 | Vaccination with Rift Valley fever virus live attenuated vaccine strain Smithburn caused meningoencephalitis in alpacas |
| Q40399200 | Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus |
| Q40516521 | Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans |
| Q40169190 | Validation of an ELISA for the concurrent detection of total antibodies (IgM and IgG) to Rift Valley fever virus. |
| Q40315842 | Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus |
| Q40443895 | Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans |
| Q40644903 | Variability of the NS(S) protein among Rift Valley fever virus isolates |
| Q58618427 | Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats |
| Q40784948 | Vector Competence of Senegalese Aedes fowleri (Diptera: Culicidae) for Rift Valley Fever Virus1 |
| Q36599998 | Vector competence of Aedes vexans (Meigen), Culex poicilipes (Theobald) and Cx. quinquefasciatus Say from Senegal for West and East African lineages of Rift Valley fever virus |
| Q47547724 | Vector competence of Culex antennatus and Anopheles coustani mosquitoes for Rift Valley fever virus in Madagascar. |
| Q34377721 | Vector competence of Egyptian mosquitoes for Rift Valley fever virus. |
| Q34744033 | Vector competence of Kenyan Culex zombaensis and Culex quinquefasciatus mosquitoes for Rift Valley fever virus |
| Q40788176 | Vector competence of a Houston, Texas strain of Aedes albopictus for Rift Valley fever virus |
| Q39195232 | Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus |
| Q40788331 | Vector competence tests with Rift Valley fever virus and five South African species of mosquito |
| Q40788381 | Vector potential of selected North American mosquito species for Rift Valley fever virus |
| Q40860033 | Vector studies on Rift Valley Fever virus in South Africa |
| Q40247447 | Vertical transmission of Rift Valley fever virus without detectable maternal viremia |
| Q40265879 | Viral Immunofluorescence with Rift Valley Fever Virus Infected MEFs in a 96 Well Plate. |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q40878515 | Virus isolation and identification from cases of Rift Valley fever virus infection in Egypt |
| Q39044207 | Virus isolations and high population density implicate Culex antennatus (Becker) (Diptera: Culicidae) as a vector of Rift Valley Fever virus during an outbreak in the Nile Delta of Egypt |
| Q40254473 | Virus-like particle-based countermeasures against Rift Valley fever virus |
| Q39653963 | Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus |
| Q44169412 | Wolbachia effects on Rift Valley fever virus infection in Culex tarsalis mosquitoes |
| Q40837874 | Zinga virus: a strain of Rift Valley fever virus |
| Q40464580 | [Feeding pattern of Rift Valley Fever virus vectors in Senegal. Implications in the disease epidemiology] |
| Q60032261 | [Isolation of Rift Valley fever virus from bats in the Republic of Guinea] |
| Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
| Q326638 | Rift Valley fever | has cause | P828 |
| Category:Rift Valley fever virus | wikimedia |
Search more.